Table 5.
Number and percentage of infested dogs examined on pre- and post-treatment days
| Study days | Number of positive dogs per endoparasite species (%) | |||||
|---|---|---|---|---|---|---|
| Trichuris vulpis | Ancylostomatidae | Capillaria aerophila | Toxocara canis | Toxascaris leonina | Dipylidium caninum a | |
| Day 0 | 20/41 (48.8) | 15/41 (36.6) | 8/41 (19.5) | 6/41 (14.6) | 7/41 (17.1) | 3/41 (7.3) |
| Day 14 | 1/41 (2.4) | 9/41 (22.0) | 0/41 (0) | 0/41 (0) | 0/41 (0) | 0/41 (0) |
| Day 28 | 2/41 (4.9) | 15/41 (36.6) | 4/41 (9.8) | 0/41 (0) | 0/41 (0) | 1/41 (2.4) |
| Day 56 | 1/41 (2.4) | 15/41 (36.6) | 0/41 (0) | 0/41 (0) | 0/41 (0) | 0/41 (0) |
| Day 84 | 1/39 (2.6) | 10/39 (25.6) | 0/39 (0) | 1/39 (2.6) | 0/39 (0) | 0/39 (0) |
| Day 112 | 0/37 (0) | 12/37 (32.4) | 0/37 (0) | 1/37 (2.7) | 0/37 (0) | 0/37 (0) |
| Day 140 | 0/37 (0) | 13/37 (35.1) | 0/37 (0) | 0/37 (0) | 0/37 (0) | 0/37 (0) |
| Day 168 | 0/37 (0) | 10/37 (27) | 0/37 (0) | 0/37 (0) | 0/37 (0) | 0/37 (0) |
aDogs found infected with Dipylidium caninum were treated with praziquantel, since this tapeworm species is not targeted by the two products tested in the study